Adenosine deaminase deficiency

14,030views

Adenosine deaminase deficiency

immu II kt

immu II kt

Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Food allergy
Anaphylaxis
Allergic rhinitis
Severe combined immunodeficiency
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Common variable immunodeficiency
DiGeorge syndrome
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Adenosine deaminase deficiency
Wiskott-Aldrich syndrome
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Complement deficiency
Leukocyte adhesion deficiency
Chronic granulomatous disease
Hashimoto thyroiditis
Graves disease
Myasthenia gravis
Diabetes mellitus
Goodpasture syndrome
Pemphigus vulgaris
Multiple sclerosis
Autoimmune hemolytic anemia
Immune thrombocytopenia
Primary biliary cholangitis
Celiac disease
Inflammatory bowel disease: Pathology review
Crohn disease
Ulcerative colitis
Sjogren syndrome
Rheumatoid arthritis
Dermatomyositis
Scleroderma
Systemic lupus erythematosus
Vaccinations: Clinical
Graft-versus-host disease
Ataxia-telangiectasia
HIV (AIDS)
HIV and AIDS: Pathology review
Immunodeficiencies: Clinical
Hyper IgM syndrome
COVID-19 vaccine hesitancy
Development of the COVID-19 vaccine
COVID-19 mutant variants and herd immunity
Imaging features of COVID-19 (LifeBridge Health)
Post-COVID syndrome: Mental health
Safety of the COVID-19 vaccines
Standards of care for COVID-19 patients
COVID-19 vaccines: What healthcare providers need to know
Post-COVID syndrome: Heart, lungs and clotting

Transcript

Watch video only

Adenosine deaminase deficiency, or ADA deficiency, is a rare genetic disease, that results in severe combined immunodeficiency, or SCID for short.

SCID can be caused by a number of causes, so this particular variation is called ADA-SCID.

Let’s take a step back. Our cells have all the instructions on how to live and behave written on their own copy of DNA.

DNA is made out of four nucleotides, which can also do all kinds of cool stuff in their free time, like provide energy to various processes in the cell.

Nucleotides are made out of a sugar, in this case deoxyribose, one to three phosphate groups, and a nucleobase, which can be adenine, thymine, cytosine, or guanine.

So, the name of a deoxyribose-containing, triphosphatic nucleotide, based on adenine, that makes up DNA would be deoxyadenosine triphosphate, or dATP, for short.

These nucleotides are needed in equal proportions in order to make cellular division run smoothly.

Now, nucleotides have a functional lifetime of their own, and our body has mechanisms on how to break them up into their building blocks, to be either excreted or recycled.

Let’s focus on deoxyadenosine triphosphate.

First the enzyme adenosine deaminase removes an amine group from it, turning it into deoxyinosine monophosphate, or dIMP.

Then purine nucleoside phosphorylase comes in and removes the phosphate and the deoxyribose from dIMP, making hypoxanthine.

Hypoxanthine is then oxidised twice by xanthine oxidase - first to become xanthine, and then finally, to uric acid.

Uric acid can then be excreted by the kidneys, in the form of urine.

Now one class of cells that divides quickly and therefore relies heavily on cell division to work smoothly are lymphocytes.

Lymphocytes protect the body from pathogens, like bacteria and viruses in two ways.

First, B lymphocytes, or B cells, produce immune proteins called antibodies, which seek out and latch on onto an invader, marking it for destruction by other cells.

Second, cytotoxic T lymphocytes, or cytotoxic T cells, as well as lymphocytes called natural killer cells, go cell to cell, looking for virally-infected cells or cells that look like they’ve started dividing uncontrollably - like a cancer cell.

If they find a cell like that, they destroy it.

Simultaneous breakdown of both of these pathways makes the immunodeficiency combined, and severe.

Hence the name, severe combined immunodeficiency.

Adenosine deaminase is encoded by a gene on chromosome 20, and typically mutations are inherited through an autosomal recessive pattern, meaning that the disease occurs when a child receives a mutant allele from both parents.

Sources

  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "Adenosine deaminase deficiency: Frequency and comparative pathology in autosomally recessive severe combined immunodeficiency" Clinical Immunology and Immunopathology (1979)
  7. "Educational paper" European Journal of Pediatrics (2011)
  8. "Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency" Stem Cells and Cloning: Advances and Applications (2009)
  9. "Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006)" Clinical Immunology (2007)